Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program
Roche acquisition of PathAI
We are advising Roche on the transaction
Cross Country Healthcare sale to Knox Lane
We are advising Cross Country Healthcare on the transaction
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
McKesson sale of minority stake in Medical-Surgical Solutions to Apollo
We are advising McKesson on the transaction
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Coloplast acquisition of Uromedica
We are advising Coloplast on the transaction